Biopharmaceutical Market Poised for USD 854.6 Billion Valuation by 2030 Driven by Chronic Disease Prevalence and Technological Advancements

The Biopharmaceutical Market size was estimated at USD 333 billion in 2022. It is expected to reach USD 854.6 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period from 2023 to 2030.

Biopharmaceuticals are medicines produced using biotechnology methods, such as recombinant DNA technology, hybridoma technology, and cell culture techniques. These drugs include monoclonal antibodies, vaccines, gene therapies, and other protein-based therapeutics. The increasing prevalence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, coupled with the growing demand for targeted and personalized therapies, is driving the expansion of the biopharmaceutical market.

The market growth is further propelled by the advancements in biotechnology, such as the development of novel drug delivery systems, the increasing adoption of gene editing technologies, and the integration of artificial intelligence in drug discovery processes. The growing investments in research and development activities and the collaborations between pharmaceutical companies and biotechnology firms are also contributing to the market's growth.

Download Free Sample Report of Biopharmaceutical Market @ https://www.snsinsider.com/sample-request/4184

List of Biopharmaceutical Market Companies Profiled in Report:
- Abbott Laboratories
- Amgen, Inc.
- AstraZeneca
- Bayer AG
- Biogen, Inc.
- bioMérieux (France)
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- F. Hoffmann-La Roche, Ltd.
- GlaxoSmithKline Plc
- Johnson & Johnson
- Lilly
- Merck & Co., Inc.
- Novartis AG
- Novo Nordisk A/S
- Pfizer, Inc.
- Sanofi

Market Analysis
The rising geriatric population and the increasing incidence of chronic diseases are key drivers for the biopharmaceutical market. The growing awareness about the benefits of biopharmaceuticals, such as their high specificity, efficacy, and safety, is also fueling the market growth. Additionally, the favorable regulatory environment, with initiatives to streamline the drug approval process and support the development of orphan drugs, is creating new opportunities for market players.

Recent Developments in the Biopharmaceutical Market
In May 2023, AbbVie Inc. announced the acquisition of Syndesi Therapeutics SA, a clinical-stage biotechnology company focused on developing novel treatments for cognitive impairment and other neurodegenerative disorders. This acquisition strengthens AbbVie's neuroscience portfolio and enhances its capabilities in the development of innovative therapies for neurological conditions. The integration of Syndesi's expertise in synaptic vesicle protein 2A (SV2A) modulators with AbbVie's research and development capabilities is expected to accelerate the discovery and commercialization of novel treatments for Alzheimer's disease and other neurodegenerative disorders.

In February 2023, Roche Holding AG launched its new SARS-CoV-2 Rapid Antibody Test, a point-of-care diagnostic tool for the qualitative detection of antibodies against the COVID-19 virus. This test utilizes Roche's innovative nanobody technology, which enables the rapid and reliable identification of individuals with recent or prior SARS-CoV-2 infection. The launch of this test underscores the growing importance of biopharmaceutical solutions in the fight against infectious diseases and the potential of nanobody technology in the development of rapid diagnostic tools.

The Biopharmaceutical Market Is Segmented By Product, Application, and Geography.

By Product:
• Monoclonal Antibodies
• Recombinant Growth Factors
• Purified Proteins
• Recombinant Proteins
• Recombinant Hormone
• Vaccines
• Synthetic Immunomodulators
• Other

Monoclonal Antibodies - This segment currently holds the largest share due to the high efficacy and specificity of monoclonal antibodies in treating various diseases, such as cancer and autoimmune disorders.

Recombinant Proteins, Vaccines, Cell and Gene Therapies, Other Products - These segments are expected to witness significant growth owing to the increasing adoption of novel biopharmaceutical modalities and the growing investments in their research and development.

By Application:
• Oncology
• Inflammatory and Infectious Diseases
• Autoimmune Disorders
• Metabolic Disorders
• Hormonal Disorders
• Cardiovascular Diseases
• Neurological Diseases
• Other

Oncology - This segment accounts for a substantial share due to the high prevalence of cancer and the increasing demand for targeted therapies.

Autoimmune Diseases, Infectious Diseases, Neurological Disorders, Other Applications - These segments are anticipated to experience robust growth due to the rising incidence of chronic diseases and the development of innovative biopharmaceutical treatments.

By Raw Material Type
• Formulation Excipients
• Active Pharmaceutical Ingredients (API)
• Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support

Have Any Query? Ask Our Experts @ https://www.snsinsider.com/enquiry/4184

Impact of Russia-Ukraine War on the Biopharmaceutical Market
The ongoing Russia-Ukraine war is likely to have a limited direct impact on the biopharmaceutical market, as neither country is a major player in the global biopharmaceutical industry. However, the war may indirectly affect the market through disruptions in the supply chain of raw materials and manufacturing components, potentially leading to temporary shortages and price fluctuations.

Impact of Economic Slowdown on the Biopharmaceutical Market
An economic slowdown could potentially affect the biopharmaceutical market, particularly in terms of healthcare spending and patient affordability. However, the impact is expected to be moderate, as biopharmaceuticals are essential for the treatment of critical diseases, and their demand is likely to remain stable even during economic downturns. Moreover, the long-term growth prospects of the biopharmaceutical market remain positive, driven by the increasing prevalence of chronic diseases and the continuous advancements in biotechnology.

North America Is Expected To Hold The Largest Market Share Throughout The Forecast Period
This dominance can be attributed to factors such as the presence of well-established pharmaceutical and biotechnology companies, the high healthcare expenditure, and the increasing investments in research and development activities in the region. Europe is also expected to hold a significant share, driven by the growing demand for personalized medicine, the increasing prevalence of chronic diseases, and the supportive regulatory environment for orphan drug development. Asia-Pacific is projected to witness the highest growth rate, owing to the rapidly expanding healthcare infrastructure, the increasing disposable income, and the growing awareness about the benefits of biopharmaceutical treatments in the region.

Key Takeaways for Market Report Purchasers
- A comprehensive analysis of the biopharmaceutical market, encompassing current trends, growth drivers, and challenges.
- Insightful segmentation of the market by Product, Application, and Geography, providing a thorough understanding of each segment's dynamics.
- Evaluation of the impact of the Russia-Ukraine war and economic slowdown on the market's growth trajectory.
- In-depth examination of key regional developments and the factors influencing market dominance.

Purchase Biopharmaceutical Market Report @ https://www.snsinsider.com/checkout/4184

Table of Content
Chapter 1 Introduction
Chapter 2 Research Methodology
Chapter 3 Biopharmaceutical Market Dynamics
Chapter 4 Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)
Chapter 5 Value Chain Analysis
Chapter 6 Porter's 5 forces model
Chapter 7 PEST Analysis
Chapter 8 Biopharmaceutical Market Segmentation, By Product type
Chapter 9 Biopharmaceutical Market Segmentation, By Raw Material Type
Chapter 10 Biopharmaceutical Market Segmentation, By Application
Chapter 11 Regional Analysis
Chapter 12 Company profile
Chapter 13 Competitive Landscape
Chapter 14 Use Case and Best Practices
Chapter 15 Conclusion
Continued…

Other Reports
Telehealth and Telemedicine Market: https://whatech.com/og/markets-research/medical/836751-telehealth-and-telemedicine-market-size-share-analysis-and-to-surpass-usd-818-87-billion-by-2031

Healthcare IT Integration Market: https://whatech.com/og/markets-research/medical/836756-healthcare-it-integration-market-size-trends-growth-and-forecasted-to-reach-usd-12-40-billion-by-2031

Contact Us:
Akash Anand - Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 | +91-7798602273 (IND)

About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

This release was published on openPR.